News + Press

Texas Biomed Gains $2.7 Million NIH Grant to Develop New Methods to Understand Genetic Basis of Diseases | 08.15.2014

The Texas Biomedical Research Institute has been awarded a $2.7 million grant from the U.S. National Institutes of Health to fund innovative approaches to genetics research aimed at developing new therapies for heart disease and other conditions with genetic components. | Read the full story

Robert Gracy Named Interim CEO at Texas Biomed | 07.22.2014

Robert W. Gracy, Ph.D., has been named Interim President and Chief Executive Officer of Texas Biomedical Research Institute, according to Board Chairman Richard Schlosberg. | Read the full story

Texas Biomed Regenerative Medicine Program Expands With Two New Research Scientists | 06.11.2014

Texas Biomedical Research Institute has recruited two new research scientists to its Southwest National Primate Research Center (SNPRC) who will focus on regenerative medicine, working with animal models to develop human stem cell therapies for medical conditions such as Parkinson’s disease, degenerative diseases of the eye and muscular dystrophy. Tiziano Barberi, PhD and Marcel M. Daadi, PhD join Texas Biomed as Associate Scientists in the SNPRC. | Read the full story

Trevett Announces Resignation as Texas Biomed CEO | 05.29.2014

SAN ANTONIO, May 28, 2014 - Texas Biomedical Research Institute has announced the resignation of Kenneth P. Trevett as its President and CEO, according to Board Chairman Richard Schlosberg. Trevett will continue in the position until a successor is hired. | Read the full story

A new method for isolating and genome sequencing malaria parasites will aid in the understanding of these infections | 05.08.2014

A new method for isolating and genome sequencing an individual malaria parasite cell has been developed by Texas Biomed researchers and their colleagues. This advance will allow scientists to improve their ability to identify the multiple types of malaria parasites infecting patients and lead to ways to best design drugs and vaccines to tackle this major global killer. | Read the full story

Texas Biomed president and CEO Kenneth P. Trevett named health care hero for philanthropy by San Antonio Business Journal | 04.29.2014

Kenneth P. Trevett, J.D., president and chief executive officer of the Texas Biomedical Research Institute, has been designated a 2014 ‘Health Care Hero’ in the philanthropic champion category by the San Antonio Business Journal. The annual award honors leaders in the city’s health care and biomedical fields. | Read the full story

Help The Texas Biomedical Forum match a $20,000 gift for scientific research through Big Give S.A.! | 04.23.2014

The Texas Biomedical Forum “The Forum”, through the Big Give S.A. is asking you to help raise $20,000 in a 24-hour period on Tuesday, May 6th that will be matched dollar for dollar. Each year The Forum sponsors seed monies for pilot study grants to the scientists at Texas Biomed. | Read the full story

Texas Biomed dedicates Earl Slick Research Center, a new 70,000 square foot laboratory and scientific support building to speed discovery | 03.24.2014

The Texas Biomedical Research Institute’s new $27 million science complex, funded entirely by donors, will be dedicated at 2:30 pm on March 27. It is part of a campus master plan that includes a major effort to recruit world-class scientists, enhance existing research programs and initiate new ones to accelerate the pace of discovery. | Read the full story

New study of human blood fluke parasites identifies drug resistance mutations; raises hopes for improved therapies | 11.21.2013

An international group of scientists led by Tim Anderson Ph.D., at the Texas Biomedical Research Institute and Philip LoVerde Ph.D., at the University of Texas Health Science Center at San Antonio has identified the mutations that result in drug resistance in a parasite infecting 187 million people in South America, Africa and Asia. The new finding allows detailed understanding of the drugs’ mechanism of action and raises prospects of improved therapies. | Read the full story

New baboon studies may help explain why some people who take drugs for osteoporosis are at risk for leg bone fractures | 11.14.2013

Research with baboons at the Texas Biomedical Research Institute may help explain why some people who take bone-strengthening drugs like bisphosphonates are at-risk for atypical fractures in the long bones in their legs. | Read the full story